Results 161 to 170 of about 122,654 (313)

5‐Methylcytosine Analysis of miRNAs in Minimal Change Disease

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Minimal change disease (MCD) is a glomerular disorder, which is the most common cause of nephrotic syndrome in children. Additionally, the prevalence of MCD in adults has been increasing in recent years. During protein synthesis, noncoding RNAs can be regulated through a variety of modifications, which helps preserve biological diversity and ...
Huiyi Zeng   +14 more
wiley   +1 more source

Interactome Quantitation Reveals Non-Energetic Mitochondrial Roles in Cell Type Specialization in Murine Kidney. [PDF]

open access: yesMol Cell Proteomics
Bakhtina AA   +6 more
europepmc   +1 more source

Nanostructured Conducting Polyaniline Tubules as Catalyst Support for Pt Particles for Possible Fuel Cell Applications [PDF]

open access: bronze, 2004
B. Rajesh   +5 more
openalex   +1 more source

On the role of the epithelium in a model of sodium exchange in renal tubules [PDF]

open access: green, 2020
Marta Marulli   +3 more
openalex   +1 more source

Beyond right or wrong: How partial credit scoring on multiple‐choice questions improves student performance and assessment perceptions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims In this study, we examined the effects of assigning partial credit to selected answer choices on student performance and perceptions in a pharmacology course using Type A multiple‐choice questions (MCQs). Methods Partial credit scoring was incorporated into quizzes and exams in a 10‐week pharmacology course for postbaccalaureate premedical ...
Stephen D. Schneid   +2 more
wiley   +1 more source

In vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis. [PDF]

open access: yesSci Adv
Kristensen AM   +11 more
europepmc   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee   +5 more
wiley   +1 more source

Kidney Tubule Secretion and AKI After Cardiac Surgery. [PDF]

open access: yesKidney Int Rep
Gutiérrez OM   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy